Clinical and Prognostic Effect of Plasma Fibrinogen in Renal Cell Carcinoma: A Meta-Analysis

Figure 3

Results of subgroup analysis of the association between plasma fibrinogen and clinicopathological parameters. (a) The pooled OR from three studies including 1941 stage T1 and T2 and 276 stage T3 and T4 cases. (b) The pooled OR from three studies including 1430 grade G1 and G2 and 787 grade G3 and G4 cases. (c) The pooled OR from three studies including 1834 ccRCC and 383 non-ccRCC cases. (d) A total of 2277 RCC patients were pooled from three studies to assess whether plasma fibrinogen in RCC was associated with gender. ccRCC: clear cell renal cell carcinoma; RCC: renal cell carcinoma.

(a)

(b)

(c)

(d)